Institutional Sign In

Go

GlaxoSmithKline Czech Republic - Cash Earnings

GlaxoSmithKline CR`s Cash Earnings reached 72.9 CZK mil in 2017. This is 57.1 % more than in the previous year.

$1.99

Buy Cash Earnings data for GlaxoSmithKline Czech Republic.

$19.99

Buy all data for GlaxoSmithKline Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic CZK mil ... ... ... ... ...             48.2 30.6 31.0 42.4 37.8    
Bayer Czech Republic CZK mil ... ... ...                 174 91.3 104 111 128    
GlaxoSmithKline Czech Republic CZK mil ... ... ...                 259 182 147 108 136    
Merck Czech Republic CZK mil ... ...                   50.5 64.7 28.4 35.9 69.8    
Novartis Czech Republic CZK mil                       46.7 55.8 61.4 97.5 102    
Pfizer Czech Republic CZK mil ... ...                   245 51.0 147 136 87.5    
Roche Czech Republic CZK mil ... ... ...                 175 174 280 226 179   ...
Sanofi-Aventis Czech Republic CZK mil ... ... ... ...               63.0 54.8 74.8 8.23 63.7    
Servier Czech Republic CZK mil ... ... ... ... ... ... ... ... ... ... ... ... 14.6 15.6 16.1 19.3    
Walmark CZK mil ... ... ...                 308 89.0 83.7 152 -629